Yuichi Yoshida

2.5k total citations
142 papers, 1.5k citations indexed

About

Yuichi Yoshida is a scholar working on Dermatology, Epidemiology and Oncology. According to data from OpenAlex, Yuichi Yoshida has authored 142 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Dermatology, 33 papers in Epidemiology and 27 papers in Oncology. Recurrent topics in Yuichi Yoshida's work include Neurofibromatosis and Schwannoma Cases (21 papers), Cancer and Skin Lesions (21 papers) and Soft tissue tumor case studies (16 papers). Yuichi Yoshida is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (21 papers), Cancer and Skin Lesions (21 papers) and Soft tissue tumor case studies (16 papers). Yuichi Yoshida collaborates with scholars based in Japan, United States and Luxembourg. Yuichi Yoshida's co-authors include Osamu Yamamoto, Kimio Kunimori, Keiichi Tomishige, Yōko Arai, Shigeru Kado, Nanako Yamada, Hiroaki Yasuda, Baitao Li, Mohammad Nurunnabi and Koji Adachi and has published in prestigious journals such as Green Chemistry, Materials Science and Engineering A and Fuel.

In The Last Decade

Yuichi Yoshida

122 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichi Yoshida Japan 18 361 230 182 177 175 142 1.5k
Jinli Liu China 19 199 0.6× 218 0.9× 11 0.1× 151 0.9× 162 0.9× 68 2.3k
Jorge Heller United States 27 83 0.2× 68 0.3× 81 0.4× 694 3.9× 164 0.9× 69 2.6k
Xi He China 14 50 0.1× 133 0.6× 5 0.0× 206 1.2× 73 0.4× 29 967
Yongjun Liu China 17 136 0.4× 78 0.3× 8 0.0× 219 1.2× 165 0.9× 59 1.6k
Tianbin Ren China 29 84 0.2× 53 0.2× 9 0.0× 906 5.1× 369 2.1× 76 2.3k
Suong Hyu Hyon Japan 21 467 1.3× 25 0.1× 20 0.1× 527 3.0× 113 0.6× 47 2.2k
Melanie MacGregor Australia 22 28 0.1× 45 0.2× 35 0.2× 635 3.6× 279 1.6× 64 1.4k
Yufeng Wang China 23 31 0.1× 75 0.3× 5 0.0× 868 4.9× 195 1.1× 93 1.9k
Min Hui Wang United States 20 18 0.0× 76 0.3× 15 0.1× 95 0.5× 123 0.7× 62 1.6k
Michaela Schulz‐Siegmund Germany 24 10 0.0× 94 0.4× 30 0.2× 702 4.0× 94 0.5× 80 2.0k

Countries citing papers authored by Yuichi Yoshida

Since Specialization
Citations

This map shows the geographic impact of Yuichi Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichi Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichi Yoshida more than expected).

Fields of papers citing papers by Yuichi Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichi Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichi Yoshida. The network helps show where Yuichi Yoshida may publish in the future.

Co-authorship network of co-authors of Yuichi Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichi Yoshida. A scholar is included among the top collaborators of Yuichi Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichi Yoshida. Yuichi Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Okanishi, Tohru, Masanobu Fujimoto, Hiroyuki Awano, et al.. (2025). Multidisciplinary Management of Plexiform Neurofibromas in Pediatric Patients With Neurofibromatosis 1: Insights From Advisory Board‐Guided Clinical Experience in Japan. The Journal of Dermatology. 53(1). 135–139.
3.
Sugita, Kazunari, et al.. (2025). Chronological Changes in CD8 + T Cells and Granzyme B in Ulcerative Lesions During Mogamulizumab Therapy for Mycosis Fungoides. Journal of Cutaneous Pathology. 53(3). 215–218. 1 indexed citations
4.
Sanefuji, Masafumi, Takuji Nakamura, Hidetaka Niizuma, et al.. (2024). Clinical characteristics and management of plexiform neurofibromas in children with neurofibromatosis 1: A Japanese nationwide survey. Brain and Development. 47(1). 104300–104300.
5.
Yoshida, Yuichi, et al.. (2022). Health‐related quality of life in patients with neurofibromatosis 1 in Japan: A questionnaire survey using EQ‐5D‐5L. The Journal of Dermatology. 49(12). 1228–1232. 7 indexed citations
6.
Goto, Hiroyuki, Yuichi Yoshida, & Osamu Yamamoto. (2021). Late contralateral lymph node metastasis of basal cell carcinoma on the scrotum. European Journal of Dermatology. 31(5). 654–655. 1 indexed citations
7.
Koga, Monji, et al.. (2019). Distribution of diffuse plexiform neurofibroma on the body surface in patients with neurofibromatosis 1. The Journal of Dermatology. 47(2). 190–192. 10 indexed citations
8.
Yoshida, Yuichi, et al.. (2018). Large number of cutaneous neurofibromas beyond age‐appropriate incidence in a patient with a large deletion of NF1. The Journal of Dermatology. 45(3). 363–364. 1 indexed citations
9.
Yoshida, Yuichi, et al.. (2018). Simple method for estimating cutaneous neurofibromas in patients with neurofibromatosis 1. The Journal of Dermatology. 45(5). 626–627.
10.
Yamamoto, Osamu, et al.. (2017). Clinical severity in Japanese patients with neurofibromatosis 1 based on DNB classification. The Journal of Dermatology. 44(11). 1262–1267. 14 indexed citations
11.
Yamamoto, Osamu, et al.. (2017). Natural course and characteristics of cutaneous neurofibromas in neurofibromatosis 1. The Journal of Dermatology. 45(1). 53–57. 20 indexed citations
12.
Takenouchi, Toshiki, Chiharu Torii, Atsushi Shimizu, et al.. (2014). The Use of Next-Generation Sequencing in Molecular Diagnosis of Neurofibromatosis Type 1: A Validation Study. Genetic Testing and Molecular Biomarkers. 18(11). 722–735. 30 indexed citations
13.
Osaki, Mitsuhiko, Yuichi Yoshida, Osamu Yamamoto, et al.. (2013). Decreased PITX1 gene expression in human cutaneous malignant melanoma and its clinicopathological significance. European Journal of Dermatology. 23(3). 344–349. 19 indexed citations
14.
Ito, Arisa, et al.. (2012). A Case of Pyoderma Gangrenosum with Henoch-Sch^|^ouml;nlein Purpura. The Nishinihon Journal of Dermatology. 74(5). 493–496. 1 indexed citations
15.
Yoshida, Yuichi, et al.. (2012). Fatigue Life Prediction in Spot Welded Rectangular Section Members under Springback Effect. Journal of the Japan Society for Technology of Plasticity. 53(621). 919–923. 1 indexed citations
16.
Yoshida, Yuichi, et al.. (2009). Aggressive Subcutaneous Panniculitis-like T-cell Lymphoma. The Nishinihon Journal of Dermatology. 71(3). 275–277. 1 indexed citations
17.
Yoshida, Yuichi, et al.. (2008). Development of Laser Spot Welded Stainless Steel Double Skin Panels for Rail Vehicle Body. Journal of the Japan Society for Precision Engineering. 74(12). 1287–1291. 1 indexed citations
18.
Yoshida, Yuichi & Juichiro NAKAYAMA. (2007). Efficacy of and Parents' Impression of Epinastine Hydrochloride Dry Syrup in the Treatment of Pediatric Patients with Itching Skin Diseases. The Nishinihon Journal of Dermatology. 69(2). 192–196. 1 indexed citations
19.
Yoshida, Yuichi, Kazunori Urabe, Hong Duan, et al.. (2003). Basal Cell Carcinomas in Association with Basaloid Follicular Hamartoma. Dermatology. 207(1). 57–60. 16 indexed citations
20.
Yoshida, Yuichi, et al.. (1995). Combined Chemotherapy with Intralesional Interferon-.BETA. Injection for Malignant Melanoma in a Patient with Werner's Syndrome.. The Nishinihon Journal of Dermatology. 57(4). 741–745. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026